ESOPHAGEAL ADENOCARCINOMA

This study compared two established procedures for treating Barrett's esophagus, a condition that increases cancer risk. Researchers wanted to see which method caused less pain and discomfort for patients after treatment. The trial involved 62 adults and measured pain levels, swa…

This first-in-human study tested a new drug called Cabotamig in 33 adults with advanced gastrointestinal cancers that had stopped responding to standard treatments. The main goals were to check the drug's safety, see how the body processes it, and look for early signs that it mig…

This study tested the safety and how the body processes an experimental drug called SGN-B6A in Chinese patients with advanced solid tumors. It involved a small group of 6 participants who had cancers like lung, head and neck, or stomach cancer that had stopped responding to stand…

This completed Phase 3 trial tested whether adding the targeted drug trastuzumab (Herceptin) to standard treatment improves outcomes for people with a specific type of esophageal cancer (HER2-positive). The standard treatment involved chemotherapy, radiation, and surgery. Researc…

This study looked back at past patients to see if low oxygen levels after esophageal cancer surgery are linked to a higher chance of the surgical connection leaking. Researchers reviewed the records of over 2000 patients who had this surgery, comparing those with low oxygen to th…